You are here: Home: Meet The Professors - Breast Cancer 1 | 2008: Faculty Affliations and Disclosures
Faculty Affiliations
Content Validation and Disclosures Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. FACULTY — Dr Geyer — No real or apparent conflicts of interest to disclose. The following
faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have
been resolved through a conflict of interest resolution process: Dr Budd — Advisory Committee: Amgen Inc, AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation, Pfizer Inc,
Wyeth. Dr Gralow — Consulting Agreements: Amgen Inc, Genentech BioOncology, Genomic
Health Inc, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Roche Laboratories Inc,
Sanofi-Aventis. COMMUNITY PANEL — Drs Allison, Astrow, Bobrow, Hoffman, Levy, Lunin and Schwartz — No real or apparent conflicts of interest to disclose. Dr Marcom — Preceptorship: Novartis Pharmaceuticals Corporation, Sanofi-Aventis. Dr Moss — Advisory Committee: Celgene Corporation, Millennium Pharmaceuticals Inc, Pharmion Corporation; Paid Research: Abraxis BioScience, Amgen Inc, Archimedes Development Limited, Eisai Inc, Genentech BioOncology, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, Pharmatech Inc, Sanofi-Aventis, Taiho Pharmaceutical Co Ltd. Dr Seigel — Stock Ownership: AstraZeneca Pharmaceuticals LP, Celgene Corporation, Genentech BioOncology, Millennium Pharmaceuticals Inc. Dr Vacirca — Speakers Bureau: Abraxis BioScience, OSI Pharmaceuticals Inc, Sanofi-Aventis. RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose. This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors. Medical Oncologist Community Panel
|
Faculty Affiliations and Disclosures
|
Terms of Use and General Disclaimer | Privacy Policy Copyright © 2008 Research To Practice. All Rights Reserved |